Research output per year
Research output per year
-
Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020
Kopra, E. I., Ferris, J. A., Winstock, A. R., Kuypers, K. P. C., Young, A. H. & Rucker, J. J., 6 Mar 2023, (E-pub ahead of print) In: Journal of Psychopharmacology.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
A Comparison of Acute Neurocognitive and Psychotomimetic Effects of a Synthetic Cannabinoid and Natural Cannabis at Psychotropic Dose Equivalence
Theunissen, E. L., Kuypers, K. P. C., Mason, N. L. & Ramaekers, J. G., 19 May 2022, In: Frontiers in Psychiatry. 13, 14 p., 891811.Research output: Contribution to journal › Article › Academic › peer-review
Open Access1 Citation (Web of Science) -
Analgesic potential of macrodoses and microdoses of classical psychedelics in chronic pain sufferers: a population survey
Bonnelle, V., Smith, W. J., Mason, N. L., Cavarra, M., Kryskow, P., Kuypers, K. P. C., Ramaekers, J. G. & Feilding, A., Dec 2022, In: British Journal of Pain. 16, 6, p. 619-631 13 p., 20494637221114962.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile20 Downloads (Pure) -
A systematic review of (pre)clinical studies on the therapeutic potential and safety profile of kratom in humans
Prevete, E., Kuypers, K. P. C., Theunissen, E. L., Corazza, O., Bersani, G. & Ramaekers, J. G., Jan 2022, In: Human psychopharmacology. 37, 1, 33 p., e2805.Research output: Contribution to journal › (Systematic) Review article › peer-review
Open Access7 Citations (Web of Science) -
Author Correction: Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls
Rootman, J. M., Kiraga, M., Kryskow, P., Harvey, K., Stamets, P., Santos-Brault, E., Kuypers, K. P. C. & Walsh, Z., 28 Jul 2022, In: Scientific Reports. 12, 1, 1 p., 12925.Research output: Contribution to journal › Erratum / corrigendum / retractions › Academic
Open Access
Datasets
-
Psychotomimetic symptoms after a moderate dose of a synthetic cannabinoid (JWH-018): implications for psychosis
Theunissen, E. (Creator), Reckweg, J. (Creator), Hutten, N. (Creator), Kuypers, K. (Creator), Toennes, S. W. (Creator), Neukamm, M. A. (Creator), Halter, S. (Creator) & Ramaekers, J. (Creator), DataverseNL, 4 Oct 2021
DOI: 10.34894/ayuyq1, https://dataverse.nl/citation?persistentId=doi:10.34894/AYUYQ1
Dataset
-
Intoxication by a synthetic cannabinoid (JWH-018) causes cognitive and psychomotor impairment in recreational cannabis users
Theunissen, E. (Creator), Reckweg, J. (Creator), Hutten, N. (Creator), Kuypers, K. (Creator), Toennes, S. W. (Creator), Neukamm, M. A. (Creator), Halter, S. (Creator) & Ramaekers, J. (Creator), DataverseNL, 4 Oct 2021
DOI: 10.34894/8ugj0a, https://dataverse.nl/citation?persistentId=doi:10.34894/8UGJ0A
Dataset
Press/Media
-
Waarom onderzoeker Kim Kuyper razend enthousiast is over de inzet van partydrugs in de ggz
22/03/23
1 Media contribution
Press/Media: Expert Comment › Popular
-
Microdosering: word je door kleine porties hallucinerende drugs een betere versie van jezelf? ‘Je doet alles met een bepaalde focus’
14/03/23
1 Media contribution
Press/Media: Expert Comment › Popular
-
Podcast DOCS #108 : De Tripgeneratie
18/01/23
1 Media contribution
Press/Media: Expert Comment › Popular
-
MindMed Initiates Phase 2a LSD Trial for the Treatment of Adult ADHD
2/11/21 → 20/12/21
186 items of Media coverage
Press/Media: Research › Popular
-
Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) to C
16/12/21
1 item of Media coverage
Press/Media: Research › Popular